The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure
Authors:
- Cristina AlmengloCACristina Almenglo
- Ángel Luis FernandezÁFÁngel Luis Fernandez
- Jose Manuel Martinez-CereijoJMJose Manuel Martinez-Cereijo
- Diego Iglesias-AlvarezDIDiego Iglesias-Alvarez
- Darío Duran-MuñozDDDarío Duran-Muñoz
- Tomás García-CaballeroTGTomás García-Caballero
- Jose Ramón Gonzalez-JuanateyJGJose Ramón Gonzalez-Juanatey
- Moises Rodriguez-MañeroMRMoises Rodriguez-Mañero
- Sonia EirasSonia Eiras
Open Access
Abstract
Epicardial fat thickness is associated with cardiovascular disease. Mineralocorticoid receptor antagonist (MRA), a pharmaceutical treatment for CVD, was found to have an effect on adipose tissue. Our aim was to analyse the main epicardial fat genesis and inflammation-involved cell markers and their regulation by risk factors and MRA. We included blood and epicardial or subcutaneous fat (EAT or SAT) from 71 patients undergoing heart surgery and blood from 66 patients with heart failure. Cell types (transcripts or proteins) were analysed by real-time polymerase chain reaction or immunohistochemistry. Plasma proteins were analysed by Luminex technology or enzyme-linked immunoassay. Our results showed an upregulation of fatty acid transporter levels after aldosterone-induced genesis. The MRA intake was the main factor associated with lower levels in epicardial fat. On the contrary, MRA upregulated the levels and its secretion of the anti-inflammatory marker intelectin 1 and reduced the proliferation of epicardial fibroblasts. Our results have shown the local MRA intake effect on fatty acid transporters and anti-inflammatory marker levels and the proliferation rate on epicardial fat fibroblasts. They suggest the role of MRA on epicardial fat genesis and remodelling in patients with cardiovascular disease. Translational perspective: the knowledge of epicardial fat genesis and its modulation by drugs might be useful for improving the treatments of cardiovascular disease.Keywords
Funding Information
- Instituto de Salud Carlos III (PI19/01330)
- Xunta de Galicia (ED431B 2016/022)
This publication has 59 references indexed in Scilit:
- Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro StudiesPLOS ONE, 2013
- Impact of Mineralocorticoid Receptor Antagonists on Changes in Cardiac Structure and Function of Left Ventricular DysfunctionCirculation: Heart Failure, 2013
- Pref-1, a Gatekeeper of AdipogenesisFrontiers in Endocrinology, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Coronary Atherosclerosis Is Associated With Macrophage Polarization in Epicardial Adipose TissueJACC, 2011
- CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrowJournal of Clinical Investigation, 2010
- Left Atrial Epicardial Adiposity and Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2010
- Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesityAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Adipocyte/macrophage fatty acid–binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in miceJournal of Clinical Investigation, 2008
- Immune Regulation by helminth parasites: cellular and molecular mechanismsNature Reviews Immunology, 2003